Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Alcohol%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?lookfor=%22Alcohol%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?lookfor=%22Alcohol%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (3.750)
1
Randomised, double-blind, placebo-controlled trial evaluating the effects of naltrexone hydrochloride nasal spray on alcohol consumption in Alcohol Use Disorder : Randomised, double-blind, placebo-controlled trial evaluating the effects of naltrexone hydrochloride nasal spray on alcohol consumption in Alcohol Use Disorder - Effects of intranasal naltrexone on Alcohol Use Disorder
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Different doses of BI 1467335 compared to placebo in patients with clinical evidence of NASH : A multi-centre, double-blind, parallel-group, randomised, placebo controlled phase II a study to investigate safety, tolerability, pharmacodynamics, and harmacokinetics of different doses of orally administered BI 1467335 during a 12-week treatment period compared to placebo in patients with clinical evidence of NASH. - PoM in target population
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A Clinical trial to evaluate safety, and effectiveness of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis. : A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Tirzepatide versus placebo in NASH : A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparingthe Efficacy and Safety of Tirzepatide versus Placebo in Patients withNonalcoholic Steatohepatitis (NASH) - SYNERGY-NASH
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A Clinical trial to evaluate safety, and effectiveness of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH) : A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A study to investigate the efficacy and safety of Aramchol in patients with a form of fatty liver disease. : A Phase 3, Multinational, Multicenter, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects with Nonalcoholic Steatohepatitis (NASH)The ARMOR Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Safety, Tolerability, and Pharmacodynamics of PF-05221304 in subjects with Nonalcoholic Fatty Liver Disease : A Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate Safety, Tolerability, And Pharmacodynamics Of PF-05221304 Administered Daily For 16-Weeks To Adult Subjects With Nonalcoholic Fatty Liver Disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Randomised, double-blind, placebo-controlled trial evaluating the effects of naltrexone hydrochloride nasal spray on alcohol consumption in Alcohol Use Disorder : Randomised, double-blind, placebo-controlled trial evaluating the effects of naltrexone hydrochloride nasal spray on alcohol consumption in Alcohol Use Disorder - Effects of intranasal naltrexone on alcohol use disorder
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A study to investigate the efficacy and safety of Aramchol in patients with a form of fatty liver disease. : A Phase 3/4, Multinational, Multicenter, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects with Nonalcoholic Steatohepatitis (NASH)The ARMOR Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Clinical trial comparing different doses of norursodeoxycholic acid capsules with placebo in the treatment of non-alcoholic fatty liver disease : Double-blind, randomized, placebo-controlled, phase II dose-finding study comparing different doses of norursodeoxycholic acid capsules with placebo in the treatment of non-alcoholic fatty liver disease (NAFLD) - Norursodeoxycholic acid vs. Placebo in NAFLD
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[375]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
3.750
Aufsätze
3.750
E-Artikel
3.750
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
3.750
610
3.266
Study Type: Interventional
1.228
Recruitment Status: Not yet recruiting
1.046
Recruitment Status: Completed
780
Recruitment Status: Recruiting
538
Phase: Phase 2
408
Study Type: Observational
328
Recruitment Status: Authorised-recruitment may ...
280
Phase: Phase 3
208
Recruitment Status: Complete: follow-up complete
118
Medical Condition: Health Condition 1: F102- Al...
90
Phase: Phase 4
84
Phase: Phase 2/Phase 3
70
Medical Condition: non-alcoholic fatty liver di...
54
Medical Condition: Non-alcoholic fatty liver di...
48
Recruitment Status: Complete: follow-up continuing
46
Medical Condition: ;F10.2 - Mental and behaviou...
46
Phase: Phase 1
42
Phase: Other
36
Medical Condition: Non-alcoholic fatty liver di...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2.712
2020-
1.038
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
3.720
Englisch
16
Unbestimmt
6
Spanisch
4
Deutsch
2
Französisch
2
Latein
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...